201
202
200
203
204

Address: Calwerstraße 14
72076 Tübingen


Person profile: 07071 29-82311


Fax number: 07071 29-4141


Current information on our studies

We regularly conduct scientific studies on various issues.

Study participants wanted!

We are looking for participants for many studies. Find out more about participating in a study.

Neuropsychiatric Study Center

Supports the GCP-compliant conduct of studies of the Center for Neurology, the University Department of Psychiatry and Psychotherapy and the Department of Neurosurgery by providing central services.

Learn more

Studies after diagnosis

Studies after diagnosis

Name of the study
Explanation
Contact Us
links
Currently no ongoing studies


Name of the study
Explanation
Contact Us
links
Currently no ongoing studies



Name of the study
Explanation
Contact Us
links

BOSSFRONT2


Comparison of a new, individualized TMS therapy with standard TMS therapy in patients with depression.


anne.lieb@med.uni-tuebingen.de
Study information (PDF)

PMDS/PDD


Our study aims to investigate how the menstrual cycle affects mood and cognitive performance in healthy women, women with premenstrual dysphoric disorder (PMDS) and women with a current major depressive episode (MDD).


menstruation-und-stimmung@med.uni-tuebingen.de
Study information (PDF)
Ketamine plus CBASP
Efficacy of ketamine and Cognitive Behavioral Analysis System of Psychotherapy (CBASP) therapy for depression.
Anne.Rau@med.uni-tuebingen.de
To the page
CBASP
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in inpatients with persistent depressive and treatment-resistant disorders: Effectiveness, moderators and mediators of change
Kerstin.Velten-Schurian@med.uni-tuebingen.de

Study information (PDF)
Early TMS study on depression
Study on transcranial magnetic stimulation as an early treatment option for depression.
zfh@med.uni-tuebingen.de

To the page
Name of the study
Explanation
Contact Us
links

BI 1402-0030


The study investigates the safety and efficacy of a newly developed drug. It is being investigated whether the new drug BI 1358894 can help people with post-traumatic stress disorder (PTSD).


anne.rau@med.uni-tuebingen.de
Study information (PDF)

Prism PTSD


The planned study will investigate the effectiveness of treatment with the novel Prism system in reducing clinical symptoms of post-traumatic stress disorder (PTSD), using a specific biofeedback method as an adjunct to standard treatment.


clp006-studienzentrum@med.uni-tuebingen.de
Study information (PDF)
Name of the study
Explanation
Contact Us
links

MECT-RESIST


The main objective of the study is to test the hypothesis that maintenance ECT (mECT) in combination with treatment as usual (TAU) (intervention arm) is superior to TAU alone (control arm) for relapse prevention in clozapine-resistant schizophrenia (CRS).


sarah.kayser@med.uni-tuebingen.de
Study information (PDF)

Biomarker evaluation to support clinical translation for schizophrenia

Start: 01.09.2021
End: 31.08.2024


Psychoses are a group of disorders of extraordinary heterogeneity. As a result, diagnosis, prognosis and treatment decisions for individual patients are a major challenge. The project optimizes biomarker signatures of patients at high risk for schizophrenia and patients with defined psychotic disorders. This will be achieved by integrating multimodal patient data and subsequent functional validation of biomarker signatures on patient-derived neurons.


Project leader: Prof. Dr. Hansjürgen VolkmerFunded

by: BMBFProject management organization

: DLRFKZ

: 01EK2101A




Name of the study
Explanation
Contact Us
links

Epigenetics in alcohol dependence


In our study "Characterization of novel epigenetic biomarkers of alcohol dependence, treatment success and relapse risk" we are investigating the influence of chronic alcohol dependence on the epigenome and how the epigenome changes in the course of alcohol withdrawal treatment.


susanne.edelmann@med.uni-tuebingen.de
Study information (PDF)
Study website
Name of the study
Explanation
Contact Us
links

Inhibition of return

The aim of the study is to investigate a reaction time task. It will investigate how the phenomenon of visual attention called "inhibition of return" changes in Alzheimer's dementia. In addition, it will be examined whether the reaction time task also provides valid results when collected using a tablet, as previous studies have implemented the task using a computer screen and buttons.


christoph.gaebele@student.uni-tuebingen.de

Study information (PDF)

Study flyer (PDF)


Name of the study
Explanation
Contact Us
links

Obsessive-compulsive disorder and information processing

The aim of the study is to determine the relationship between obsessive-compulsive disorder and processes of information processing, learning and decision-making. The aim is to examine the extent to which these processes influence the symptoms (and vice versa) and whether a reduction in symptoms - for example as part of therapy - is accompanied by changes in these cognitive processes.


tue-ocd-project@klinikum.uni-tuebingen.de
Study information (PDF)

Studies by method

Studies by method

Name of the studyExplanationContactLinks
Ghrelin: work versus reward
Study on the effects of ghrelin administration on dopamine and performance.
neuromadlab@klinikum.uni-tuebingen.de
Interested in how stomach and brain communicate?
flyer
website
In search of rewards
Study on the relationship between reward learning and metabolic signaling. How do we process rewards in the brain?
neuromadlab@klinikum.uni-tuebingen.de
Interested in your metabolism. Then learn more:
website
CARE
Computer-assisted risk evaluation and risk-adapted treatment for increased risk of developing psychosis.
psychiatrische-hochschulambulanz@med.uni-tuebingen.de
website
CBASPCognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in inpatients with persistent depressive and treatment-resistant disorders: Efficacy, moderators, and mediators of changechristian.frischholz@med.uni-tuebingen.de


TBS-DEffects of transcranial direct current stimulation (tDCS) and cognitive training in patients with schizophrenia
Efficacy of bilateral theta burst stimulation in the treatment of depression.
zfh@med.uni-tuebingen.deTo the page
Information for patients
BEDVAR

Eating Behavior and Reward Processing Study. What processes promote the development of binge eating?

neuromadlab@klinikum.uni-tuebingen.deFlyer
StimADHD
Review of the efficacy of transcranial direct current stimulation (tDCS) for ADHD in adults
stimadhd@med.uni-tuebingen.de
To the page
Hormonal contraception, mood and cognitive abilities
Study on the effects of the pill on cognitive abilities and mood
neuromadlab@klinikum.uni-tuebingen.de

Would you like to learn more about the effects of the pill?

Website

Flyer


Name of the study
Explanation
Contact
Links

Biomarker evaluation to support clinical translation in schizophrenia

Start: 01.06.2021End
: 31.05.2024


Psychosis represents a group of diseases signified by enormous heterogeity. As a consequence, diagnosis, prognosis, and treatment decision for individual patients are pretty challenging. Within the project, we shall optimize biomarker signatures of patients with high risk for schizophrenia and with defined psychotic disease. This will be achieved by integration of multimodal patient data and subsequent validation of biomarker signatures with the help of patient-derived neurons.

Project leader: Prof. Dr. Hansjürgen Volkmer

Project funding: BMBF

Project sponsor: DLR

Funding reference number: 01EK2101A



Certificates and Associations